Structure |
Chemical Name |
CAS |
MF |
|
Tazobactam Impurity XTE |
|
|
|
Isavuconazole Impurity 46 |
|
|
|
5-(1-((5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino)-2-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one |
2226428-25-5 |
C24H28N2O3 |
|
INDEX NAME NOT YET ASSIGNED |
2740235-22-5 |
C13H22N2O5 |
|
2-(4-ethylpiperazin-1-yl)-4-(2-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine |
|
C23H30FN3 |
|
1-Naphthalenamine, 4-(2,3-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-, (1R,4S)-rel- |
2184053-08-3 |
C17H17Cl2N |
|
Rosuvastatin Impurity 152 |
|
|
|
1-(4-(2-(アゼパン-1-イル)エトキシ)ベンジル)-5-(ベンジルオキシ)-2-(4-(ベンジルオキシ)フェニル)-3-メチル-1H-インドール |
198480-21-6 |
C44H46N2O3 |
|
6-Heptenoic acid, 7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-, 1,1-dimethylethyl ester, (3S,5R,6E)- |
2273873-66-6 |
C29H32FNO4 |
|
2H-1,4-Benzoxazin-3(4H)-one, 8-(2-chloro-1-hydroxyethyl)-6-(phenylmethoxy)- |
2383660-53-3 |
C17H16ClNO4 |
|
Isavuconazole Impurity 40 |
|
|
|
(2R,3S,4R,5R,6S)-2-((R)-1,2-dihydroxyethyl)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)tetrahydro-2H-pyran-3,4,5-triol |
|
|
|
2,3'-Bipyridine, 5-chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-, 1,1'-dioxide |
2724840-93-9 |
C18H15ClN2O4S |
|
Vitamin K1 Impurity C |
|
|
|
4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1-((5-methylpyridin-3-yl)methyl)piperidine 1-oxide |
|
|
|
1-(4-Bromo-2-(hydroxymethyl)phenyl)-4-(dimethylamino)-1-(4-fluorophenyl)butan-1-olhydrochloride |
488148-10-3 |
C19H23BrFNO2 |
|
Bisoprolol Impurity 42 |
|
|
|
Peramivir Impurity 31(R) |
|
|
|
Pitavastatin 5-Oxo Impurity Calcium Salt |
2180095-22-9 |
C25H24CaFNO4 |
|
1-(2-bromo-3,5-dihydroxyphenyl)ethanone |
2092614-65-6 |
C8H7BrO3 |
|
Lenvatinib impurity LFZZ-18 |
|
C11H8Cl2N2O2 |
|
Rosuvastatin Impurity 121 |
140164-51-8 |
C10H18O5 |
|
Brivaracetam Impurity 38 |
|
|
|
Isavuconazole Impurities 04 |
|
|
|
Ticagrelor Impurity 119 |
|
|
|
Ticagrelor Impurity 118 |
|
|
|
D-erythro-Hexonic acid, 2,4-dideoxy-3,5-O-(1-methylethylidene)-, acetate (9CI) |
402508-35-4 |
C11H18O6 |
|
L-Alanine, 3-[(S)-(carboxymethyl)sulfinyl]- |
112246-66-9 |
C5H9NO5S |
|
2-Propanone, 1-[4,5-dihydro-2-(4-methyl-1-piperazinyl)-4-thioxo-3H-1,5-benzodiazepin-3-ylidene]- |
1902955-67-2 |
C17H20N4OS |
|
3(2H)-Pyridazinone, 6-[4-(ethylamino)phenyl]-4,5-dihydro-5-methyl- |
52240-42-3 |
C13H17N3O |
|
Benzoic acid, 4-[[4-(aminocarbonyl)-1-piperidinyl]methyl]- |
938143-02-3 |
C14H18N2O3 |
|
1-(4-methylbenzyl)-1,4,8,11-tetraazacyclotetradecane tetrahydrochloride |
|
|
|
2,4-bis(1-(2,3-dimethylphenyl)ethyl)-1H-imidazole |
|
|
|
2-((4R,6S)-6-((2-((4R,6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetoxy)methyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetic acid |
|
|
|
1,3-bis(4-((E)-3-methoxy-3-oxoprop-1-en-1-yl)benzyl)-1H-imidazol-3-ium bromide |
|
|
|
Crisaborole intermediate |
1187230-70-1 |
C14H14BNO3 |
|
Glycine, (2R)-N-[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]-2-phenylglycyl-2-[(2S,4S)-4-carboxy-5,5-dimethyl-2-thiazolidinyl]-, (2R)- |
1449784-97-7 |
C23H29N5O8S |
|
6-Quinolinecarboxamide, 4-[(2-chloro-4-hydroxyphenyl)amino]-7-methoxy- |
2380197-89-5 |
C17H14ClN3O3 |
|
1-Pyrrolidineacetic acid, α-ethyl-2-oxo-4-propyl-, methyl ester, (4R)- |
930123-52-7 |
C12H21NO3 |
|
Traxipide impurity |
|
|
|
Benzeneacetic acid, 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazol-2-yl]-1-piperidinyl]ethyl]-α,α-dimethyl-, methyl ester |
1181267-38-8 |
C29H39N3O3 |
|
Benzenemethanol, 4-[2-(1-methylethoxy)ethoxy]- |
1039828-27-7 |
C12H18O3 |
|
Brivaracetam Impurity 7 HCl |
357338-46-6 |
C13H27ClN2O3 |
|
Bisacodyl Impurity 1 |
13004-51-8 |
C18H15NO2 |
|
Vecuronium Bromide ImpurityACDEFGHJKL |
|
|
|
Butanedioic acid, 2-[[2-methyl-1-(phenylmethyl)-1H-imidazol-5-yl]methylene]-, 1-ethyl ester, (2E)- |
1640981-02-7 |
C18H20N2O4 |
|
INDEX NAME NOT YET ASSIGNED |
2452300-94-4 |
C21H25ClO8 |
|
1-Butanone, 1-(4-fluorophenyl)-4-[(6bS,10aS)-2,3,6b,9,10,10a-hexahydro-3-methyl-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl]- |
1576240-15-7 |
C24H28FN3O |
|
1-Pyrrolidineacetamide, α-ethyl-4-(1-methylethyl)-2-oxo-, (αS,4S)- |
357334-83-9 |
C11H20N2O2 |
|
impurity 42 |
|
|
|
3-(hydroxy(2-methyl-1H-imidazol-1-yl)methyl)-9-(hydroxymethyl)-1,2,3,9-tetrahydro-4H-carbazol-4-one |
|
|
|
Perospirone Impurity 18 |
|
|
|
Perospirone Impurity 3 |
1002359-81-0 |
C8H11NO2 |
|
Roxatidine Impurity 10 |
|
|
|
Dolutegravir Impurity 13(Sodium Salt) |
|
|
|
Paxlovid Impurity 10 |
|
|
|
Fondaparinux sodium impurity 4 |
|
|
|
Ampicillin Impurity W |
|
|
|
Lasmiditan Impurity 5 |
|
|
|
Olodaterol Impurity 18 |
2727170-18-3 |
|
|
Febuxostat impurity DAC |
|
|
|
1-メチル-2-オキソシクロペンタンカルボン酸エチル |
5453-88-3 |
C9H14O3 |
|
Olodaterol Impurity 27 |
|
|
|
Ethacridine Impurity 9 |
|
|
|
isopropyl 2-(2-(4-chlorobenzoyl)phenoxy)-2-methylpropanoate |
|
|
|
32,50-Dicarboxy-cyanoco balamin |
|
|
|
Olodaterol Impurity 30 |
|
|
|
3-(2-アミノエチル)-N-メチル-1H-インドール-5-メタンスルホンアミド |
88919-22-6 |
C12H17N3O2S |
|
3'-Epi Gemcitabine |
103882-85-5 |
C9H11F2N3O4 |
|
4-Chloro-6,7-bis-(2-chloroethoxy)quinazoline |
183322-21-6 |
C12H11Cl3N2O2 |
|
4-Hydroxy Omeprazole |
301669-82-9 |
C16H17N3O3S |
|
2-(3,4-dihydroxyphenyl)-2-hydroxy-acetaldehyde |
13023-73-9 |
C8H8O4 |
|
BRN 0758154 |
69304-48-9 |
C11H13IN2O5 |
|
NSC4751 |
5393-61-3 |
C10H10N2O2 |
|
Sts 64 |
24284-84-2 |
C21H27NO2 |
|
2-ヒドロキシ-N-[3-[3-(ピペリジノメチル)フェノキシ]プロピル]アセトアミド·塩酸塩 |
97900-88-4 |
C17H26N2O3 |
|
3,5-ジ(ブロモメチル)ピリジン |
35991-75-4 |
C7H7Br2N |
|
alpha-Hydroxy-alpha-phenylbenzeneacetic acid (3-endo)-8-azabicyclo[3.2.1]oct-3-yl ester hydrochloride |
63516-30-3 |
C21H24ClNO3 |
|
N-[4-(メチルアミノ)ベンゾイル]-L-グルタミン酸 |
52980-68-4 |
C13H16N2O5 |
|
(2R)-N-(2,6-DIMETHYLPHENYL)-2-PIPERIDINECARBOXAMIDE |
27262-43-7 |
C14H20N2O |
|
Aids004544 |
145397-25-7 |
C8H10FN3O4 |
|
1,3-ビス(9H-カルバゾール-4-イルオキシ)-2-プロパノール(CARVEDILOL IMPURITY) |
1276477-91-8 |
C27H22N2O3 |
|
2-Carboxybenzoyl Amlodipine |
318465-73-5 |
C28H29ClN2O8 |
|
rac-trans-4-Desfluoro-4-methoxy Paroxetine Hydrochloride |
127017-74-7 |
C20H24ClNO4 |
|
[4-[3-(イソプロピルアミノ)-2-ヒドロキシプロピルオキシ]フェニル]メタノール |
62572-93-4 |
C13H21NO3 |
|
Desmethoxy Fluvoxamine |
1217216-82-4 |
C14H19F3N2O |
|
4'-Deoxy Vincristine |
68135-16-0 |
C46H56N4O9 |
|
Demethyl Chlorpromazine Hydrochloride |
3953-65-9 |
C16H18Cl2N2S |
|
1-シクロプロピル-4-オキソ-6-ヒドロキシ-7-ピペラジノ-1,4-ジヒドロキノリン-3-カルボン酸 |
226903-07-7 |
C17H19N3O4 |
|
N-(2-Succinyl) Fluvoxamine |
259526-43-7 |
C19H25F3N2O6 |
|
Methylene-Bis Paroxetine Dihydrochloride |
606968-05-2 |
C39H40F2N2O6 |
|
Nicorandil N-Oxide |
107833-98-7 |
C8H9N3O5 |
|
2-Phenyl-1-[4-(trifluoromethyl)phenyl]ethane 2-(Aminoethyl)oxime (Fluvoxamine Impurity) |
1217241-15-0 |
C17H17F3N2O |
|
CIS-モンテルカスト |
774538-96-4 |
C35H36ClNO3S |
|
(S)-(-)-トルバプタン |
331947-44-5 |
C26H25ClN2O3 |
|
N-tert-Butoxycarbonyl Mirabegron |
1329485-55-3 |
C26H32N4O4S |
|
Phosphine oxide, tris (2-methylphenyl)- |
6163-63-9 |
C21H21OP |
|
1,2,4-Triazolo[4,3-a]pyrazine, 7-[3-amino-1-oxo-4-(2,4,5-trifluorophenyl)-2-butenyl]-5,6,7,8-tetrahydro- 3-(trifluoromethyl)- |
847445-81-2 |
C16H13F6N5O |
|
4-Difluoromethoxy-2-nitro-aniline |
97963-76-3 |
C7H6F2N2O3 |
|
(1R,3S)-1-(1,3-ベンゾジオキソール-5-イル)-2,3,4,9-テトラヒドロ-1H-ピリド[3,4-B]インドール-3-カルボン酸メチルエステル |
171596-44-4 |
C20H18N2O4 |